Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment

AIDS Research and Human Retroviruses

Volumn 18, Issue 5, 2002, Pages 341-342

  Boffito, Marta ^a,b   Rossati, Antonella ^b   Reynolds, Helen E ^a   Hoggard, Patrick G ^a   Back, David J ^a   Di Perri, Giovanni ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; DIAMORPHINE; EFAVIRENZ; METHADONE; OPIATE; PROTEINASE INHIBITOR;

ARTICLE; BACTERIAL PNEUMONIA; BEHAVIOR; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG USE; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAINTENANCE THERAPY; PRIORITY JOURNAL; URINALYSIS; WITHDRAWAL SYNDROME;

ANTI-HIV AGENTS; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; KINETICS; METHADONE; NARCOTICS; OXAZINES; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0036207054     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202753519115     Document Type: Article

References (5)

1. Interactions among drugs for HIV and opportunistic infections
2. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz
3. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone
4. Efavirenz decreases methadone blood concentrations